More on Vermillion (VRML): Q1 beats on the top line with higher OVA1 product sales, but misses...

|By:, SA News Editor

More on Vermillion (VRML): Q1 beats on the top line with higher OVA1 product sales, but misses on its EPS. Net losses increased as one-time items, including costs related to the delayed 2012 annual shareholder meeting held in March, a proxy contest and CEO transition all weighed on margins. Shares -18.7% AH.